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Using Ion Mobility Spectrometry–Mass Spectrometry to Decipher the
Conformational and Assembly Characteristics of the Hepatitis B Capsid
Protein
Dale A. Shepherd, Kris Holmes, David J. Rowlands, Nicola J. Stonehouse,* and Alison E. Ashcroft*
Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom
ABSTRACT The structural and functional analysis of the core protein of hepatitis B virus is important for a full understanding of
the viral life cycle and the development of novel therapeutic agents. The majority of the core protein (CP149) comprises the
capsid assembly domain, and the C-terminal region (residues 150–183) is responsible for nucleic acid binding. Protein mono-
mers associate to form dimeric structural subunits, and helices 3 and 4 (residues 50–111 of the assembly domain) have been
shown to be important for this as they constitute the interdimer interface. Here, using mass spectrometry coupled with ion
mobility spectrometry, we demonstrate the conformational flexibility of the CP149 dimer. Limited proteolysis was used to locate
involvement in this feature to the C-terminal region. A genetically fused CP dimer was found to show decreased disorder, consis-
tent with a more restricted C-terminus at the fusion junction. Incubation of CP149 dimer with heteroaryldihydropyrimidine-1, a
small molecule known to interfere with the assembly process, was shown to result in oligomers different in shape to the capsid
assembly-competent oligomers of the fused CP dimer. We suggest that heteroaryldihydropyrimidine-1 affects the dynamics of
CP149 dimer in solution, likely affecting the ratio between assembly active and inactive states. Therefore, assembly of the less
dynamic fused dimer is less readily misdirected by heteroaryldihydropyrimidine-1. These studies of the flexibility and oligomer-
ization properties of hepatitis B virus core protein illustrate both the importance of C-terminal dynamics in function and the utility
of gas-phase techniques for structural and dynamical biomolecular analysis.
INTRODUCTION
Hepatitis B virus (HBV) poses a major risk to human health,
with chronic infections in excess of 350 million worldwide
(1). These infections are associated with a significantly
increased occurrence of hepatocellular carcinoma (2). HBV
is an enveloped virus with a partially double-stranded DNA
genome. The genome codes for four classes of protein: the
surface antigen, the reverse transcriptase, the X protein (a
transcription activator), and the capsid (core) protein (CP).
A detailed understanding of the virus replication cyclewould
aid the development of new remedies, and one possible target
for future antiviral therapy is the virus assembly process.
In vivo virus assembly is initiated by the association of the
pre-genomic RNA with the reverse transcriptase and core
proteins and results in the formation of icosahedral nucleo-
capsids (3); however, the core protein has the ability to
assemble spontaneously into capsid-like particles in vitro.
Recent studies conducted on the in vitro assembly of the
HBV core protein have focused on the recombinant
C-terminally truncated assembly domain as a model system
for capsid assembly (4–7). The core protein assembly
domain up to residue 149 is dimeric and has been shown
to form capsids in vitro that are indistinguishable from those
isolated in phosphate-buffered saline from infected patients
(8). These capsids are composed of either 90 or 120 dimers
each, with T ¼ 3 or T ¼ 4 icosahedral symmetry, respec-
tively. Theoretical modeling of the assembly process has
suggested that aggregation occurs through a kinetically
limited mechanism nucleated by a trimer of dimers (6),
and it has been proposed that weak cation binding induces
a crucial conformational change in vitro (5). Other evidence
for a nucleus composed of a trimer of dimers has come from
structural studies using ion mobility spectrometry–mass
spectrometry (IMS-MS) with a CP140 construct that sug-
gested an incomplete capsid five-fold vertex as the assem-
bly-competent conformation of this nucleus (9).
The x-ray crystal structure of the intact T ¼ 4 capsid (10)
(Fig. 1, a and b) shows the HBV core protein to be predom-
inantly a-helical, with five helices linked by flexible loops.
Helices 3 and 4 of each monomer make up the intermonomer
interface, a four-helix bundlewith a disulphide bond between
the two Cys61 residues. The C-terminal region following he-
lix 5 lacks structure and has high crystallographic B factors.
The four conformers (A to D) are very similar and both A/B
and C/D dimers have well-defined two-fold symmetry.
However, using x-ray crystallography an assembly-
incompetent Y132A mutant has been shown to aggregate
into asymmetric dimers, with the main differences in the
spike regions. This has led to speculation that a conforma-
tional switch between assembly active and inactive states
is key for assembly (7). NMR spectroscopy has shown the
C-terminus to be subject to high picosecond dynamics,
and that asymmetry is induced in the structure of the core
protein on binding to anti-HBV peptides (11). In addition,
kinetic hydrolysis experiments have suggested a major un-
folding event in the C-terminal region in both capsid and
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dimer forms (12). However, the conformeric signature of
wild-type HBV core protein, and any changes that may be
involved in or required for the start of its assembly into cap-
sids, has not been defined in any detail.
Noncovalent electrospray ionization–mass spectrometry
(ESI-MS) is accepted as a valuable technique employed in
structural biology for studying the conformational proper-
ties of proteins and the stoichiometry and dynamics of
biomolecular assemblies (13,14). More recently, with the
commercial introduction of integrated traveling-wave
IMS-MS instrumentation (15,16), additional information
describing the three-dimensional structure of biomolecules
is now readily accessible (17). IMS provides structural in-
formation by measuring the time taken for ions to traverse
a buffer gas-filled ion mobility cell. The arrival time
observed for an ion can be used to calculate its rotationally
averaged collision cross-sectional area (CCS), which is a
description of the shape of the ion. Using travelling-wave
IMS-MS, CCS values can be estimated after calibrating
the IMS device using protein standards of known CCSs
(18–20). IMS-MS has been used to study the conformational
properties of both ordered (21–24) and intrinsically disor-
dered proteins (25–30), the latter displaying a high degree
of structural heterogeneity making them less tractable for
analysis by established techniques such as NMR and x-ray
crystallography, in addition to providing mass, stoichiom-
etry, and low-resolution structural information for a multi-
tude of species populated within heterogeneous systems,
including viral protein complexes (31–33).
The majority of structural data on the HBV core protein
has been obtained from studies of intact capsids by x-ray
crystallography (7,10) and cryoelectron microscopy
(34,35), and a few studies have generated data on the preas-
sembled dimer (11,12). Here, we used noncovalent ESI-MS
coupled with traveling-wave IMS to gain insights into the
conformational dynamics of a dimer of the C-terminally
truncated assembly domain (CP149 dimer) and the proper-
ties of capsid assembly-related and -unrelated oligomeric
species. We have demonstrated the direct measurement
and characterization of copopulated conformeric species
of various CP149 dimers with differing extents of disorder.
Limited proteolysis and comparison of CP149 dimer with a
C-terminally fused CP dimer suggest that the disorder
observed in the former is significant and lies within the
C-termini. Furthermore, a small molecule reported else-
where to inhibit HBV core assembly (36) has been found
to induce the formation of noncapsid assembly-competent
oligomers, which are shown to differ in their three-dimen-
sional shape from assembly-competent fused CP dimer olig-
omers. The data not only illustrate the use of ESI-IMS-MS
in characterizing protein disorder and protein complex
structure, but also the importance of the CP149 C-terminus
in HBV capsid dynamics, assembly, and stability.
MATERIALS AND METHODS
Protein expression and purification
CP149 capsids (expressed as described previously (36)) were treated with
4 M urea and subjected to gel filtration on a sepharose S300 size exclusion
column (GE Healthcare Bio-Sciences, Piscataway Township, NJ) to sepa-
rate protein dimer from nondisassembled capsid. CP149 dimer was dia-
lyzed against 50 mM ammonium acetate (pH 7.5/9.5) using Slide-a-lyzer
FIGURE 1 The structure of the HBV core protein (10). (a) The core protein is predominantly a-helical and exists as a dimer. Each monomer contains five
helices numbered from the N- to the C-terminus, linked by loop regions. Helices 3 and 4 constitute the four-helix bundle that forms the intermonomer inter-
face. The C-terminus is unstructured in the crystal structure and is preceded by a trypsin cleavage site at R127 (yellow). The monomers in the dimer are
covalently bound through a disulphide bond between the two C61 residues (green). (b) The T ¼ 4 capsid of HBV with each quasiequivalent conformer indi-
cated with a different color. The color coding of conformers A (green), B (yellow), C (red), and D (blue) is consistent with that used by others (PDB ID 1QGT).
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dialysis cassettes (3,500 MWCO, ThermoPierce, Rockford, IL). Dithio-
threitol (DTT) was added from a 1-M aqueous stock solution to a final con-
centration of 2 mM as required. The fused dimer CP was expressed and
purified in a similar way to CP149.
The amino acid sequence of CP149 is as follows: MDIDPYKEFG
ATVELLSFLP SDFFPSVRDL LDTASALYRE ALESPEHCSP HHTA
LRQAIL CWGELMTLAT WVGNNLEDPA SRDLVVNYVN TNMG
LKIRQL LWFHISCLTF GRETVLEYLV SFGVWIRTPP AYRPPNAPIL
STLPETTVV.
NanoESI-MS and ESI-IMS-MS of CP149 dimer
Spectra were acquired using a Synapt HDMS orthogonal acceleration quad-
rupole-traveling wave IMS-time-of-flight mass spectrometer (Micromass
UK, Waters Corp., Manchester, UK). In-house assembled, gold-plated
borosilicate vials were used for sample introduction and nanoESI. The
nanoESI capillary voltage was set at 1.4 kV. Cone voltages of a maximum
of 40 V were used with trap and transfer collision voltages of 6 V and 4 V,
respectively. The trap flow rate was 0.1 ml min1. The trap DC biases were
4 V in MS mode and 10 V in IMS mode. The source pressure was 2.8 mbar.
All data were analyzed using the MassLynx 4.1 software package supplied
with the instrument.
For measurement of the CCS of CP149 dimer, the traveling-wave IMS
device was calibrated with denatured equine cytochrome c and horse heart
myoglobin (10 mM, 50:40:10 MeCN/H2O/acetic acid, v/v) using CCS
values determined using conventional IMS-MS and available from the data-
base of Clemmer (www.indiana.edu/~clemmer) (18). The traveling-wave
IMS wave height and wave velocity were optimized at 10 V and 300 m
s1, respectively. CCS values were calculated from drift time measurements
using the procedure outlined previously (20). The CCS values are quoted as
an average of at least three measurements with errors propagated from the
error in the calibration curve. Theoretical CCS values were calculated for
monomeric and dimeric CP149 extracted from the Protein Data Bank
(PDB) structure PDB ID 1QGTusing the Leeds method (20) andMOBCAL
(37) projection approximation algorithms.
Trypsin proteolysis was used to assess the dynamic nature of the CP149
dimer C-terminus. Modified porcine trypsin (sequencing grade, Promega,
Madison, WI) was added to CP149 dimer to a final molar ratio of 1:35
(trypsin:dimer) in 50 mM ammonium acetate solution (pH 7.5). The
mixture was incubated at 20C (heating to 37C would induce assembly)
and the proteolysis reaction was monitored over several hours/days. Spectra
were acquired under the same conditions as intact CP149 dimer. The ratios
of compact to extended CP149 dimer, D1C, and D2C conformers were
assessed by centering the MS spectra by peak area and summing the area
for each of the charge state ions populated by the folded/compact protein
ions. The charge state ions assigned as compact and extended for CP149
dimer were 9þ to 13þ and 14þ to 20þ, respectively; those assigned as
compact and extended for D1C were 9þ to 13þ and 14þ to 20þ, respec-
tively; those assigned as compact and extended for D2C were 8þ to 12þ
and 13þ to 17þ, respectively.
The fused dimer CP was dialyzed against a solution of ammonium ace-
tate (50 mM). The pH was adjusted to 9.5 with ammonia solution to prevent
neutral pH-driven protein assembly. DTT (final concentration 2 mM) was
added to prevent the formation of interdimer disulphide bonds. Spectra
were acquired under the same conditions as CP149 dimer to facilitate
comparison of the spectra. Folded to unfolded ratios were estimated using
the same method as described for CP149 dimer.
ESI-MS and ESI-IMS-MS analysis of
heteroaryldihydropyrimidine-induced CP149
dimer oligomers
Heteroaryldihydropyrimidine (HAP)-1 (synthesized as described previ-
ously (36)) was added to CP149 dimer (in 50 mM ammonium acetate,
pH 7.5) in various molar ratios ranging from 0.5:1 to 50:1 HAP:dimer.
NanoESI-MS was conducted with a cone voltage of 80 Vand trap and trans-
fer voltages of 10 Vand 20 V, respectively, optimized to increase the trans-
mission of the oligomeric species. The capillary voltage was 1.8 kVand the
source pressure was 5.8 mbar, with a trap flow rate of 5 ml min1. For ESI-
IMS-MS drift time measurements, a ramped wave height of 8–15 V and a
wave velocity of 250 m s1 were used. The trap DC bias was optimized
at 20 V. The traveling-wave IMS device was calibrated using the native-
like calibrants b-lactoglobulin A, avidin, concanavalin A, yeast alcohol
dehydrogenase, pyruvate kinase, and glutamate dehydrogenase (all pur-
chased from Sigma, Dorset, UK) (38). CCS values were determined as an
average of at least three measurements, and errors were quoted as a standard
deviation of the mean.
ESI-MS and ESI-IMS-MS of fused dimer CP149
dimer oligomers
Fused dimer CP oligomers were generated by disassembling fused dimer CP
capsids using urea (4 M) at high pH (50 mM ammonium acetate, pH 9.5,
2 mM DTT), and incubating at 4C for 16 h. The solution was then buffer-
exchanged (against 50 mM ammonium acetate, pH 9.5, 2 mM DTT) to
remove the urea. MS was conducted under the same conditions as the
HAP-induced oligomers. Drift times were measured under the same condi-
tions as for the HAP-induced oligomers, and the same calibrants were used.
Theoretical CCSs and modeling of CP149
oligomers
Models of CP149 oligomers were built using the Oligomer Generator func-
tionality available on the Viper database (39). PDB file 1QGT was used to
construct oligomers based around a three-fold and six-fold capsid axis. The
five-fold capsid axis oligomers were not created as they are similar in shape
to the six-fold models. Theoretical CCS values were calculated using the
Leeds method algorithm (20).
Circular dichroism spectroscopy
Circular dichroism spectroscopy was used to study the secondary structural
features of CP149 dimer and the C-terminal cleavage product D2C. Far-
ultraviolet circular dichroism spectra were acquired between 260 and
190 nm on a J-715 spectropolarimeter (Jasco UK, Great Dunmow, UK)
in triplicate and background subtracted. The background samples were
ammonium acetate (50 mM, pH 7.5) or ammonium acetate with 0.2 mM
trypsin for the cleavage reactions. Ellipticity was quoted in units of molar
ellipticity (deg cm2 dmol1).
Transmission electron microscopy (TEM)
Negative-stain TEM was carried out on a CM10 transmission electron
microscope (Phillips, Guildford, UK) at various magnifications. Samples
were mounted on hexagonal 400 mesh copper grids (Agar Scientific, Essex,
UK) via a carbon film using the Valentine technique (40) and were stained
with uranyl acetate (4% w/v).
RESULTS
Observation of disorder in the CP149 dimer
and monomer
CP149 dimer is known to assemble into capsids in vitro
at high ionic strength, neutral to low pH, and high con-
centration. To characterize the protein in terms of its
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conformational properties, we conducted noncovalent ESI-
IMS-MS on the purified CP149 dimer in solution (50 mM
ammonium acetate, pH 7.5), conditions under which the
C61–C61 intermonomer disulphide bond remains intact. Un-
der these low ionic strength conditions, CP149 dimer assem-
bles on long timescales, making it feasible to study its
properties using MS experiments, which take only minutes.
ESI-IMS-MS is capable of separating ions with the same
mass and m/z ratio but with different shapes, allowing copo-
pulated conformers arising from a single protein or protein
complex to be separated and mass measurements and CCS
estimations to be made independently on each species. The
ESI-MS m/z spectrum of CP149 dimer (Fig. 2 a) displayed
signals indicating a species of mass 33,702 Da, consistent
with the mass of the expected sequence. The spectrum ex-
hibited a bimodal charge state distribution centered on the
10þ and 17þ charge state ions, indicating a minimum of
two conformer populations with distinct solvent-accessible
surface areas, each exposing different numbers of charge-
accepting basic residues. Using the formula of de la Mora
(41), we expected the maximum number of charges a folded
protein of this mass to carry in the gas phase would be 14þ,
indicating that the lower charges (9þ to 12þ ions) are
consistent with a compact conformation. The higher charges
(13þ to 22þ ions) suggest more extended, disordered struc-
tures, despite the analysis being carried out under solvent
conditions and instrumental parameters that have been opti-
mized and established for maintaining the noncovalent inter-
actions involved in the tertiary and quaternary structure of
proteins and biomolecular complexes intact (19,20). Varying
the buffer solution conditions to assembly-unfavorable pH
(pH 9.5) had no effect on the conformational characteristics
of CP149 dimer (see Fig. S1 in Supporting Material).
The CCS values of these copopulated CP149 dimeric
conformers were estimated from the transit times of
their multiply charged ions through the IMS drift cell
(Fig. 2 b). CP149 dimer was found to populate two distinct
conformers, one compact and one more extended, consistent
with the bimodal charge state distribution observed in the
m/z spectrum (Fig. 2 a). One advantage of ESI-IMS-MS
over ESI-MS alone is that the three-dimensional data pro-
vide a detailed evaluation of precisely which charge states
are populated by each conformer. The compact conformer
(shown as squares in Fig. 2 b) was found to populate charge
states 9þ to 14þ and the extended conformer (shown as tri-
angles in Fig. 2 b) charge states 12þ to 22þ, with both con-
formers populating the intermediate charge states, 12þ to
14þ. The CCS of the compact conformer is consistent for
the four lowest charge state ions (9þ to 12þ) within the
accepted experimental error (i.e., 5–7% (19,20)), whereas
there is some increase in CCS for the higher charge state
ions (13þ and 14þ, squares) arising from this conformer,
likely due to Coulombic repulsion. The CCS value esti-
mated for the lowest charge state ions of the compact
conformer (9þ) was 24.7 5 1.1 nm2, which is consistent
with the theoretical values of 23.3 nm2 and 24.5 nm2 calcu-
lated from the crystallographic structure of the capsid (10)
using the Leeds method (20) and MOBCAL (37) projection
approximation algorithms, respectively. The CCS estima-
tions for the extended conformer increase in a linear manner
as the number of charges on the ions increases, consistent
with Coulombic repulsion. The CCS value of the lowest
charge state ions (12þ, triangles in Fig. 2 b) of the extended
conformer was estimated at 27.9 5 0.9 nm2, some 13%
greater than that of the compact conformer, indicating a
distinct expansion in shape and an increase in disorder.
FIGURE 2 ESI-MS and ESI-IMS-MS of the
CP149 dimer and monomer. (a)m/zmass spectrum
of CP149 dimer in 50 mM ammonium acetate (pH
7.5). A bimodal charge state distribution, centered
on the 10þ and 17þ charge states, consistent with
two conformers with distinct solvent accessible
surface areas is observed. (b) Charge state (z)
versus CCS (nm2) plot for CP149 dimer showing
the ion mobility separation of conformeric fam-
ilies, one compact (squares) and one extended (tri-
angles). (c) m/z mass spectrum of CP149 dimer in
50 mM ammonium acetate (pH 7.5) with 2 mM
DTT added. The charge state distribution of the
dimer overlaps with monomeric ions (stars). The
monomer populates three charge state distributions
centered on 7þ, 10þ, and 14þ ions (monomer
charge states underlined). (d) Charge state (z)
versus CCS (nm2) plot for CP149 monomer
showing the separation of three conformeric fam-
ilies, compact (squares), extended (triangles),
and very extended (circles). Error bars indicate
the standard deviation from the mean of at least
three measurements.
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To investigate whether the disulphide bond has any influ-
ence on the populations of these conformers or on dimer sta-
bility, we treated CP149 dimer with 2 mM dithiothreitol to
reduce the intermonomer disulphide linkage. This resulted
in the observation of CP149 monomer ions (7þ to 17þ) in
the m/z spectrum, in addition to some remaining dimer ions
(Fig. 2 c). There was no evidence for any reduced CP149
dimer, indicating that the dimer dissociates on reduction of
the disulphide bond. The charge state distribution of mono-
mer ions showed the presence of three distinct, copopulated
conformers centered on the 7þ, 10þ, and 14þ ions, suggest-
ing one reasonably compact and two more extended struc-
tures, and indicating the dynamic nature of the CP149
monomer when not involved in dimer formation. ESI-IMS-
MS separation of these monomeric conformers allowed their
individual CCSs to be estimated. The conformers are labeled
as compact (7þ to 12þ ions), extended (9þ to 13þ ions), and
very extended (12þ to 15þ ions) structures (Fig. 2 d). The
CCS value of the lowest charge state ions of the compact
monomer was estimated as 15.3 5 0.9 nm2, consistent
with the calculated values obtained from the crystallographic
data of the intact capsid (10) using the Leeds method and
MOBCAL projection approximation algorithms (16.0 nm2
and 15.9 nm2, respectively). The CCS values of the extended
and very extended conformations were estimated at 19.05
1.1 nm2 and 27.15 1.4 nm2, respectively. It is noteworthy
that the very extended monomer conformation has an esti-
mated CCS value similar to that of the folded dimer, indi-
cating a significant extent of conformational flexibility.
The C-terminus induces extensive disorder in the
CP149 dimer
To elucidate which region(s) of the protein is responsible for
the disorder in CP149 dimer, we conducted limited proteol-
ysis to investigate the quaternary structure and dynamics of
this protein complex. CP149 dimer (i.e., with the disulphide
bond intact) was incubated with trypsin in a 1:35 molar ratio
at 20C and proteolysis was recorded in real time using ESI-
IMS-MS (Fig. 3, a–c). During the course of the reaction,
evidence for a single cleavage of one of the two C-terminal
peptides at R127 was apparent: doubly charged peptide ions
appeared at m/z 1168 (data not shown), corresponding to the
peptide comprising residues 128–149 (2334 Da), and resid-
ual CP149 dimer lacking this peptide from one of its two
subunits was observed also (Fig. 3 b). R127 is the first C-ter-
minal amino acid residue that is susceptible to trypsinolysis,
as R133 is adjacent to P134 and hence not cleavable (see
Materials and Methods for the amino acid sequence of
CP149). The second C-terminal amino acid residue that
is susceptible to trypsinolysis is R112, but no cleavage
was detected at this site. The cleavage product observed,
CP149 dimer (1–127), where one C-terminus is lost, is
denoted as D1C. Before proteolysis, intact CP149 dimer
was observed with a bimodal charge state distribution, as
described above (Figs. 2 a and 3 a); from the m/z spectrum,
the ratio of the CP149 dimeric conformers was estimated as
70% extended versus 30% compact. This ratio remained
constant for the residual intact CP149 dimer throughout
the proteolysis experiment, that is, no protein folding or
unfolding was observed in the presence of the enzyme.
Although the m/z spectrum of the D1C proteolysis product
showed a similar bimodal charge state distribution to that
of intact CP149 dimer, a significant reduction in the amount
of disorder was indicated by the reduced ratio of its
extended to compact conformers, which was measured as
55% extended versus 45% compact protein (Fig. 3 b).
FIGURE 3 C-terminal cleavage reduces disorder of CP149 dimer. m/z
spectra of full- length CP149 dimer (red) undergoing proteolysis observed
(a) immediately after addition of 1:35 (molar ratio) trypsin; (b) after 8 h,
when the single C-terminal cleavage product, D1C, appears (green); (c)
after 24 h, when the double C-terminal cleavage product, D2C (blue), pre-
dominates. (d) Circular dichroism spectra of CP149 dimer before (black)
and after (red) cleavage of both C-termini with trypsin. The minima at
208 and 222 nm, characteristic of an a-helical fold, are present in both
spectra indicating little change in secondary structure after C-terminal
cleavage.
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As proteolysis continued, a second cleavage product was
observed, corresponding in mass to a double cleavage,
denoted as D2C, in which both subunits had lost the C-ter-
minal residues 128–149 following enzyme cleavage at the
R127 residues in both protein chains (Fig. 3 c). Again, the
charge state distribution indicated the presence of both
extended and compact conformers, but the more highly
charged ions indicative of protein disorder were reduced
further for this double cleavage product; the ratio of
extended to compact conformers for D2C was measured
as 22% versus 78%.
The differing populations of compact versus extended
conformers for CP149 dimer,D1C, andD2C observed using
noncovalent ESI-IMS-MS support the notion that the disor-
der, or flexibility, in the CP149 dimer is due primarily to its
C-terminal amino acid sequences. This observation is
further supported by the fact that the C-terminal peptide,
comprising residues 128–149, includes only one basic resi-
due, R133, which is insufficient to accommodate all of the
charges (11þ to 17þ) observed in the m/z spectrum of the
extended conformer of D2C. Indeed, the difference between
the average integer charge states of the compact (10þ) and
extended (17þ) conformer of CP149 is 7þ, indicating that
an exposure of additional basic sites must occur in the
case of the extended conformer. Removal of the C-terminal
peptide shifts the equilibrium between the compact and
extended dimeric conformations in favor of the more
ordered conformer; however, there still remains a small
amount of disorder that indicates that the C-terminus is
not quite responsible for all the disorder observed.
To check that no major structural rearrangements
occurred following cleavage of the C-terminal peptide, we
conducted circular dichroism spectroscopy before and after
proteolysis. The spectra (Fig. 3 d) show characteristic
minima at 208 and 222 nm indicative of an a-helical sec-
ondary structure as expected and demonstrate that the cleav-
age event does not disrupt the overall protein fold. Further
evidence of the retention of protein structure following
limited proteolysis comes from the ESI-IMS-MS analyses
of the cleaved forms of CP149 dimer. CCS values of D1C
and D2C over the full range of charge state ions display
similar trends to those of the intact CP149 dimer
(Fig. S2), in that similar compact and extended conforma-
tions were observed in addition to an expected, modest,
systematic decrease in CCS as a result of proteolysis with
the loss of first one, then the second, C-terminal peptide.
As expected, cleavage of the C-termini abrogated assembly
(Fig. S3). It has been previously demonstrated that residues
up to 140 inclusive are necessary for assembly (9,42,43).
Conformational flexibility is required
for assembly
To explore further the role that the C-terminus contributes to
the disorder observed in the CP149 dimer, we constructed
and analyzed a fused CP149 dimer in which one C-terminus
is restricted by a C- to N-terminal linker. The fused dimer
was expressed as a single polypeptide linked by five Gly-
Gly-Ser repeats from the C-terminus of one monomeric sub-
unit to the N-terminus of the next (Fig. 4 a). Noncovalent
ESI-IMS-MS analysis of the fused dimer was conducted
from a solution of 50 mM ammonium acetate (pH 9.5), as
these conditions were found to be unfavorable for its self-
assembly. This was essential for the analysis of the fused
dimer as it exhibits an increased propensity to aggregate
at neutral pH, in comparison to CP149 dimer. The m/z spec-
trum of the fused dimer displayed a similar bimodal charge
state distribution of ions covering charge states 9þ to 14þ
and 15þ to 20þ (Fig. 4 b), with the latter ions being very
low in intensity. The ratio of the extended to compact fused
dimer conformers (16% vs. 84%) is significantly less than
the ratio observed for the noncovalently bound CP149 dimer
(70% vs. 30%), indicating a significantly lower degree of
disorder compared with that observed for the CP149 dimer
and a slightly lower degree of disorder than that observed
for the D1C and D2C proteolysis products.
HAP-1 induces CP149 oligomer formation but not
capsid assembly
The roles that the CP149 dimer conformers play in its
assembly were also examined. The protein was incubated
FIGURE 4 The fused dimer CP149 displays reduced dynamics. (a) A
linker of five GGS amino acid repeats links the C-terminus of one monomer
(dark gray) to the N-terminus of the second (light gray). (b) Noncovalent
ESI-MS m/z spectrum of the fused dimer CP showing a bimodal charge
state distribution centered on 11þ and 17þ ions. The high charge state dis-
tribution is low in intensity relative to that observed for CP149 dimer, sug-
gesting a reduced propensity to unfold. This is consistent with one of the
C-termini being restricted by the C-to-N-terminal linker.
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with varying concentrations of HAP-1, a compound known
to accelerate and misdirect capsid assembly (36). This small
molecule has been suggested to bind to the C-terminus of
CP149 dimer (42) and so may stabilize this region of the
protein. The addition of HAP-1 to CP149 dimer in various
ratios had little effect on the ESI-MS charge state distribu-
tion, nor did it affect the observed relative ratios of the
compact and extended dimer conformers. Furthermore, no
CP149 dimer–HAP-1 complexes were observed, indicating
that if any binding between CP149 dimer and HAP-1 did
occur, it was insufficiently robust to be maintained and/or
detected under these conditions (Fig. 5 a). However, high
m/z signals (m/z 4000–10,000) were detected that corre-
sponded to noncovalently bound oligomers consisting of
two, three, four, five, and six CP149 dimers (masses ranging
from 67.4 to 202.2 kDa), with evidence of low-intensity
signals from higher order oligomers. Such signals were
observed at CP149 dimer:HAP-1 molar ratios of 1:5 and
above. Previous work by Zlotnick et al. (36) suggested
that HAP compounds induce the formation of kinetically
trapped assembly intermediates that persist up to 24 h after
initial incubation. Although CP149 dimer had not been sub-
jected to the high ionic strength conditions favored for as-
sembly in the experiments described here, it is likely that
the oligomers observed in this MS study are related to those
species detected by Zlotnick et al. In support of this propo-
sition, TEM analysis of CP149:HAP-1 mixtures displayed
large, aberrant, noncapsid structures (Fig. 5 b) consistent
with the hexameric arrays observed by Zlotnick et al. Capsid
particles, akin to those observed under normal assembly
conditions (Fig. 5 c), were not observed in our micrographs.
ESI-IMS-MS experimentally estimated CCS values of the
HAP-induced oligomers were compared with theoretical
values modeled from atomic resolution models of CP149
oligomers with tiled shapes, that is, as they appear in the
structure of the T ¼ 4 capsid (Fig. 1 b). As demonstrated
FIGURE 5 CP149 dimer and fused dimer oligomers. (a) nanoESI-MS m/z spectrum showing CP149 forms oligomers of two (red), three (blue), four
(green), five (purple), and six (magenta) dimers in the presence of HAP-1 (10:1 molar ratio, HAP:CP149 dimer) with little change to the unbound
CP149 dimer ions remaining in the spectrum. There are also low-intensity signals indicating the presence of species greater in mass than six dimers.
(b) TEM analysis of CP149 dimer after incubation with 50:1 HAP:1 showing large, noncapsid structures and (c) a regular CP149 dimer assembly reaction
induced by 0.5 M NaCl, displaying capsid particles ~30 nm in diameter. The scale bars represent 100 nm. (d) Noncovalent ESI-MS m/z spectrum showing
fused dimer CP oligomers produced from disassembly of fused dimer CP capsids using 4 M urea. Oligomers of two (red), three (blue), four (green), and five
(purple) fused dimers are observed. (e) CCS values of core protein oligomers versus oligomer order. The fused dimer CP oligomers (red triangles) lie on the
tiled line (dashed line), whereas the HAP-induced oligomers (black squares) deviate from this, indicating a more compact structure. Error bars indicate the
standard deviation from the mean of at least three measurements.
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by Uetrecht et al. (9), the CCS values of capsid-related olig-
omeric species of the HBV core protein were consistent
with tiled morphologies. However, unlike the oligomers
observed by Uetrecht et al., the HAP-induced oligomers
detected here were not consistent with a tiled morphology
(Fig. 5 e and Table S1). The estimated CCS values of the
oligomers were more compact than the models predicted,
implying that these oligomers are not capsid-related
structures.
Our previous work has demonstrated that oligomers
isolated from CP149 fused dimer disassembly reactions
are reassembly-competent (K. Holmes, D.A. Shepherd,
A.E. Ashcroft, M. Whelan, D.J. Rowlands, and N.J. Stone-
house, unpublished). It is likely, therefore, that the shapes of
these oligomers would be different from those of the HAP-
induced oligomers. ESI-IMS-MS analysis of a fused dimer
capsid disassembly reaction yielded signals corresponding
to dimers, trimers, tetramers, and pentamers of the fused
dimer (Fig. 5 d). These oligomers are reassembly-compe-
tent, suggesting that they may recapitulate intermediate
capsid assembly states. CCS values estimated from ESI-
IMS-MS analysis showed that these fused dimer oligomers
do indeed exhibit a different trend in shape from HAP-
induced oligomers (Fig. 5 e). The values for the fused dimer
oligomers lie on a line representing capsid-derived atomic
models with tiled structures, consistent with the observa-
tion that these are assembly-competent structures. When
comparing the charge state ions of the fused dimer oligo-
mers with those of the HAP-induced oligomers, it is
apparent that the former populate, on average, higher charge
states. For example, the most intense charge state for the
tetramer of fused dimers is the 24þ ions, whereas for the
HAP-induced tetramer of CP149 dimers, this is the 20þ
ions. This is further evidence that the fused dimer oligomers
have a more extended structure with a larger solvent-acces-
sible surface area relative to the HAP-induced oligomers.
DISCUSSION
Noncovalent ESI-IMS-MS has been used to study a key
HBV antiviral target in terms of its conformational charac-
teristics and distinctive oligomerization properties. Using
noncovalent MS conditions, the CP149 dimer has been
shown to populate two quite different conformational states.
The range of charge state ions populated, together with their
measured CCS values, indicates that one conformer is
compact and the other is unfolded or extended significantly.
The disorder observed is consistent with previous NMR
studies that implied a degree of flexibility within the
C-termini (11). However, ESI-IMS-MS, which has the
ability to separate and individually measure copopulated
species rather than present an average of all molecules, in-
dicates the presence of two distinct conformeric families
and provides a comparison of their structures in terms of
shape. Although the projection approximation algorithms
used to calculate the CCS values of proteins from their
respective PDB coordinates tend to underestimate slightly
the CCS of the protein, in general they are in reasonable
(within 5%) agreement with the IMS-MS-estimated CCS
values because of a small, general compaction of protein
structure in the absence of solvent in the gas-phase experi-
ments, and thus can be used as an indicator of the compact-
ness, or foldedness, of the protein under investigation (44).
Furthermore, the presence of the intermonomer disulphide
linkage has been shown to be necessary to maintain the
dimeric nature of CP149. In the absence of this chemical
bond, the dimer dissociates into monomer, the latter having
a high degree of disorder even under the mild solution con-
ditions and instrumental parameters employed, consistent
with the weak interdimer association energy in capsids (4).
Trypsin proteolysis of the CP149 dimer resulted in a spe-
cific cleavage at R127, releasing the first 22 amino acid
residues of the C-terminus. The loss of these residues was
accompanied by a significant reduction in the intensity of
the lower m/z, more highly charged envelope of ions that
is associated with the extended conformer. As little disorder
is apparent in the two truncated products, D1C and D2C,
this suggests that the disorder associated with intact
CP149 dimer is related to the presence of the two C-termini
on account of their orientation within the quaternary struc-
ture of the dimer. This observation is consistent with the
x-ray crystal structure of the intact capsid, in which the
C-terminal peptide is unstructured (10) (Fig. 1 a), and also
with work by Hilmer et al. (12), who showed that the C-ter-
minal peptide is cleaved by trypsin in a conformation-
dependent manner.
In addition, the decrease in the population of the extended
conformers observed for the truncated dimers compared
with the intact CP149 dimer when analyzed under the
same experimental conditions is a good indication that the
compact and extended conformers detected reflect the solu-
tion behavior of these species and are not simply artifacts of
the MS technique.
The effect of the C-terminus on CP149 disorder was
tested further by ESI-IMS-MS analysis of a modified
C-to-N-terminally fused dimer of CP149. The fused dimer
has one C-terminus restricted by the linker group and
therefore should exhibit less structural disorder. This was
confirmed given that the high charge state ions correspond-
ing to the extended fused dimer conformer were much lower
in intensity than the corresponding signals observed for the
CP149 dimer. Indeed, the proportion of the extended
conformer decreased from 70% for the CP149 dimer to
16% in the case of the fused dimer, and was lower than
the values observed for both the D1C and D2C truncated
proteolysis products, which indicated the extended
conformer population to be 55% and 22%, respectively.
The oligomers generated from CP149 dimer in the pres-
ence of HAP-1, an anti-HBV small molecule and capsid-as-
sembly misdirector, were formed under noncapsid-assembly
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conditions (i.e., in the absence of any added NaCl), indi-
cating that these assemblies are not dependent on either
high ionic strength or the presence of metal cations. The
oligomers are likely analogous to the oligomers observed
by Zlotnick et al. (36), although they appear not to be kinet-
ically trapped because a significant reservoir of free CP149
dimer is still present in these samples. Zlotnick et al. re-
ported that the oligomers they observed persisted to >24 h
in some cases, which is consistent with our observations
(data not shown). The CCS values obtained from ESI-
IMS-MS analyses suggest that the HAP-induced oligomers
of CP149 dimer are not tiled, as may be expected for assem-
bly-competent complexes (9) (Table S1). The observed
oligomers have slightly but consistently more compact
structures than those expected for the tiled models, the exact
morphologies of which are not known. Incubation of HAP-1
with D2C, lacking the C-terminus and therefore the dimer–
dimer interaction interface, did not result in the formation of
oligomers, implying that the CP149 dimer oligomers
observed are formed through native C-terminus contacts
(Fig. S3). Oligomers of the CP149 fused dimer were found
to be distinctly more extended in shape compared with
HAP-induced CP149 oligomers and consistent with a tiled
assembly pattern. The capsid-assembly competence of the
fused dimer was verified using TEM, whereas the addition
of HAP-1 to the CP149 dimer did not lead to capsid assem-
bly, but rather the production of large, aberrant noncapsid
structures (Fig. 5 d). It is possible that the reduced flexibility
of the fused dimer is responsible for reduced sensitivity to
assembly misdirection by HAP-1.
The work described here highlights the importance of the
C-terminus and dynamics of the HBV CP, which influence
the conformational dynamics of the dimer, its stability,
and its assembly patterns. Distinct assembly pathways
have been highlighted, with differences in the structural
build of the oligomeric intermediates, and the nature of
small molecule-induced assembly misdirection has been
described. The combined ability of IMS and MS to separate
species within a heterogeneous mixture based on mass and
shape in a single experiment provides a valuable tool to
study myriad biological processes. Key to this study, these
techniques have been used to characterize order–disorder
transitions in proteins and protein complexes and macromo-
lecular assembly processes rapidly, using only picomolar
amounts of material. Such techniques are valuable for the
characterization of targets for future antiviral therapy.
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